HBI Deals+Insights / Business Models and Strategy

China Resources to buy GenesisCare

Macquarie-backed, state-owned conglomerate China Resources (CR) is waiting for Australian regulatory approval to buy private equity house KKR's 45% stake in oncology group GenesisCare. CR wants to continue expanding Genesis in Western Europe and to tap the Chinese market with new hospital management contracts. The deal values the company at US$1.3bn.

We would welcome your thoughts on this story. Email your views to Francesc Milla-Martinez or call 0207 183 3779.